EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹2,350.00
arrow_upward
+0.65%(+15.20) 1D
Nov 19, 3:30:03 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹2,337.50
High
₹2,374.40
Low
₹2,321.50
Mkt. cap
445.82B
Avg. vol.
238.18K
Volume
107.21K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.33
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
Open
₹2,337.50
High
₹2,374.40
Low
₹2,321.50
Mkt. cap
445.82B
Avg. vol.
238.18K
Volume
107.21K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.33
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Gap Movers: Today's Gap-Up and Gap-Down Stocks
TradingView
·
3 hours ago
Stock Market Today: Dow, S&P 500, Nasdaq 100 Futures Rise as Wall Street Awaits Anthropic’s Listing— PANW, NTES, SLS in Focus (UPDATED)
BigGo Finance
·
6 hours ago
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
JournalArta
·
34 minutes ago
Joachim Klement to Sell Stocks After S&P 500 Signal
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com